Host Dr. Ben Young invites Drs. Roni Levin and Evan Silverstein to review the current state of amblyopia treatment, ranging from the mainstays of patching and atropine drops to novel advances such as dichoptic therapy.

Below are some references regarding dichoptic therapy that were discussed in this episode:

Xiao S, Angjeli E, Wu HC, Gaier ED, et al. Luminopia Pivotal Trial Group. Randomized controlled trial of a dichoptic digital therapeutic for amblyopia. Ophthalmology. 2022 Jan;129(1):77-85.

Wygnanski-Jaffe T, Kushner BJ, Moshkovitz A, Belkin M, Yehezkel O. CureSight Pivotal Trial Group. An eye-tracking-based dichoptic home treatment for amblyopia: A multicenter randomized clinical trial. Ophthalmology. 2023 Mar;130(3):274-285.

Koc I, Bagheri S, Chau RK, Hoyek S, et al. Cost-effectiveness analysis of digital therapeutics for amblyopia. Ophthalmology. 2025 Jun;132(6):654-660.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. John Kitchens and Andy Schimel join host Dr. Jay Sridhar to discuss current and emerging applications for artificial intelligence (AI) relevant to both patients and physicians. The sweeping conversation covers resources for low-vision patients, as well as how large language models (LLMs) such as ChatGPT and Gemini can improve efficiency, creativity, and accuracy in a variety of clinical, professional, and other settings. 

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Chris Conrady and Akbar Shakoor join host Dr. Ben Young to teach us about why intraocular inflammation (IOI) sometimes occurs after intravitreal injections, how to differentiate these cases from endophthalmitis, and how to manage this potentially blinding condition.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Advocacy and policy leaders Dr. Michael Repka and Rebecca Hyder join host Dr. Andrew Pouw to share their experiences and perspectives about the Academy's work engaging with policy stakeholders. The conversation reviews recent government healthcare funding debates that may affect Medicaid and the Children's Health Insurance Program (CHIP).

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

In today’s episode, host Dr. Amanda Redfern invites Dr. Nancy Newman to share updates in the treatment of Leber hereditary optic neuropathy (LHON), covering several clinical trials underway that involve idebenone and gene therapy. 

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

In today’s episode, host Dr. Jay Sridhar is joined by Dr. Bobeck Modjtahedi to discuss the American Academy of Ophthalmology's new guidelines on autoimmune retinopathy (AIR), recently published in Ophthalmology Retina. A member of the Academy’s task force on AIR and lead author, Dr. Modjtahedi discusses a new diagnostic framework for categorizing AIR as probable, possible, or unlikely based on specific clinical criteria. The guidelines address the challenges in diagnosing this rare condition that mimics inherited retinal diseases, and outline a standardized approach to classification for both clinical practice and research.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Davinder Grover and Ronald Fellman join host Dr. Andrew Pouw to discuss their latest innovative surgical advancement: interventional valve-enhancing trabeculotomy (iVEnT), an angle-based minimally invasive glaucoma surgery (MIGS) procedure. Compared with a traditional goniotomy, this alternative approach may be less invasive, sparing tissue and offering faster visual recovery for glaucoma patients.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Michael Puente joins host Dr. Ben Young to share his experience founding the first eye clinic specifically for adult and pediatric patients with intellectual developmental delay. Dr. Puente provides practical tips for all ophthalmologists to improve their care for this vulnerable population.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Louise Mawn and Jonathan Siktberg sit down with host Dr. Amanda Redfern to share their work on a groundbreaking paradigm shift in the treatment of periorbital necrotizing fasciitis with dilute hypochlorous acid.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. M. Ali Khan and Ajay Kuriyan join host Dr. Jay Sridhar to discuss updates in the retina space, including the FDA approval of photobiomodulation for dry age-related macular degeneration (AMD), OCT and OCTA reimbursement changes, and surgical technology advances.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.